D-0724-2026 Class II Ongoing

Recalled by Rising Pharma Holding, Inc. — East Brunswick, NJ

FDA drug recall D-0724-2026 was initiated by Rising Pharma Holding, Inc. on Jul 13, 2026 and is designated Class II. Reason for recall: Presence of Precipitate: medication was crystallizing and particles floating in the bottle The recall status is ongoing. Affected quantity: 74208 units.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 13, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
74208 units

Product description

Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.

Reason for recall

Presence of Precipitate: medication was crystallizing and particles floating in the bottle

Distribution pattern

Nationwide U.S.A.

Code information

Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0724-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0724-2026. Report a data issue: hello@regdatalab.com.